{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/fr\/","title":"My\u00e9lofibrose : le recours \u00e0 des agents cibl\u00e9s d\u00e8s le d\u00e9but de la maladie pourrait prolonger l\u2019esp\u00e9rance de vie - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"VNStfUpSvr\"><a href=\"https:\/\/themedicalxchange.com\/fr\/2016\/12\/14\/58e-reunion-annuelle-et-exposition-de-lamerican-so\/\">My\u00e9lofibrose : le recours \u00e0 des agents cibl\u00e9s d\u00e8s le d\u00e9but de la maladie pourrait prolonger l\u2019esp\u00e9rance de vie<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/fr\/2016\/12\/14\/58e-reunion-annuelle-et-exposition-de-lamerican-so\/embed\/#?secret=VNStfUpSvr\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0My\u00e9lofibrose : le recours \u00e0 des agents cibl\u00e9s d\u00e8s le d\u00e9but de la maladie pourrait prolonger l\u2019esp\u00e9rance de vie\u00a0\u00bb &#8212; The Medical Xchange\" data-secret=\"VNStfUpSvr\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2016\/12\/2369_ASH_2016_fr_Fig_1A_.PNG","thumbnail_width":960,"thumbnail_height":720,"description":"San Diego \u2013 Selon une des \u00e9tudes pr\u00e9sent\u00e9es lors de la r\u00e9union annuelle de l\u2019ASH de 2016, qui portait sur les progr\u00e8s r\u00e9alis\u00e9s dans la prise en charge de la my\u00e9lofibrose, un traitement cibl\u00e9 dont l\u2019effet positif sur la survie est document\u00e9 pourrait prolonger encore plus l\u2019esp\u00e9rance de vie s\u2019il \u00e9tait administr\u00e9 d\u00e8s le d\u00e9but de la maladie. Ont notamment \u00e9t\u00e9 pr\u00e9sent\u00e9es deux importantes analyses circonstanci\u00e9es de l\u2019efficacit\u00e9 et de l\u2019innocuit\u00e9 \u00e0 long terme d\u2019un inhibiteur de la Janus kinase (JAK) dans le traitement de la my\u00e9lofibrose, une \u00e9tude de phase initiale sur l\u2019inhibition de la JAK comme pr\u00e9alable \u00e0 la greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques (GCSH) et une \u00e9tude sur un inhibiteur multikinase exp\u00e9rimental ayant fait preuve d\u2019activit\u00e9 chez des patients dont la plaquett\u00e9mie de r\u00e9f\u00e9rence \u00e9tait faible."}